Translational Potential of Fluorescence Polarization for Breast Cancer Cytopathology

Author:

Jermain Peter R.12ORCID,Kandil Dina H.3,Muzikansky Alona4,Khan Ashraf5,Yaroslavsky Anna N.16

Affiliation:

1. Advanced Biophotonics Laboratory, University of Massachusetts Lowell, Lowell, MA 01854, USA

2. Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA

3. Department of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA

4. Biostatistics Center, Massachusetts General Hospital, Boston, MA 02114, USA

5. Department of Pathology, UMass Chan Medical School-Baystate, Baystate Health, Springfield, MA 01199, USA

6. Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA

Abstract

Breast cancer is the most common malignancy in women. The standard of care for diagnosis involves invasive core needle biopsy followed by time-consuming histopathological evaluation. A rapid, accurate, and minimally invasive method to diagnose breast cancer would be invaluable. Therefore, this clinical study investigated the fluorescence polarization (Fpol) of the cytological stain methylene blue (MB) for the quantitative detection of breast cancer in fine needle aspiration (FNA) specimens. Cancerous, benign, and normal cells were aspirated from excess breast tissues immediately following surgery. The cells were stained in aqueous MB solution (0.05 mg/mL) and imaged using multimodal confocal microscopy. The system provided MB Fpol and fluorescence emission images of the cells. Results from optical imaging were compared to clinical histopathology. In total, we imaged and analyzed 3808 cells from 44 breast FNAs. Fpol images displayed quantitative contrast between cancerous and noncancerous cells, whereas fluorescence emission images showed the morphological features comparable to cytology. Statistical analysis demonstrated that MB Fpol is significantly higher (p < 0.0001) in malignant vs. benign/normal cells. It also revealed a correlation between MB Fpol values and tumor grade. The results indicate that MB Fpol could provide a reliable, quantitative diagnostic marker for breast cancer at the cellular level.

Funder

University of Massachusetts Technology Development Grant

University of Massachusetts Medical Device Innovation Program, Center for Clinical and Translational Sciences

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference39 articles.

1. (2023, January 14). Breast Cancer Facts & Figures 2022–2024. American Cancer Society, Atlanta. Available online: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf.

2. Breast cancer screening, incidence, and mortality across US counties;Harding;JAMA Intern Med.,2015

3. Diagnostic concordance among pathologists interpreting breast biopsy specimens;Elmore;JAMA,2015

4. Problematic issues in breast core needle biopsies;Schnitt;Mod. Pathol.,2019

5. Emerging molecular markers of cancer;Sidransky;Nat. Rev. Cancer,2002

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3